Full Text
The Full Text of this article is available as a PDF (71.2 KB).
Acknowledgments
Conflict of interest
None.
Footnotes
Reply to this letter can be found at doi:10.1007/s10194-008-040-z.
References
- 1.Montagna P. The primary headaches: genetics, epigenetics and a behavioural genetic model. J Headache Pain. 2008;9:57–69. doi: 10.1007/s10194-008-0026-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.International Headache Society (2004) The international classification of headache disorders, 2nd edn. Cephalalgia 24(Suppl 1):9–160 [DOI] [PubMed]
- 3.Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet. 2007;8:253–262. doi: 10.1038/nrg2045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Peedicayil J. Epigenetic therapy—a new development in pharmacology. Indian J Med Res. 2006;123:17–24. [PubMed] [Google Scholar]
- 5.Goadsby PJ, Lipton RB, Ferrari MD. Migraine—current understanding and treatment. N Engl J Med. 2002;346:257–270. doi: 10.1056/NEJMra010917. [DOI] [PubMed] [Google Scholar]
- 6.The Sumatriptan Cluster Headache Study Group Treatment of acute cluster headache with sumatriptan. N Engl J Med. 1991;325:322–326. doi: 10.1056/NEJM199108013250505. [DOI] [PubMed] [Google Scholar]
- 7.Schürks M, Kurth T, Jesus J, Jonjic M, Rosskopf D, Diener HC. Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache. 2006;46:1246–1254. doi: 10.1111/j.1526-4610.2006.00534.x. [DOI] [PubMed] [Google Scholar]
- 8.Schürks M, Kurth T, Stude P, et al. G protein beta3 polymorphism and triptan response in cluster headache. Clin Pharmacol Ther. 2007;82:396–401. doi: 10.1038/sj.clpt.6100159. [DOI] [PubMed] [Google Scholar]